-
Mashup Score: 0A Way to Make Asthma Drugs in Inhalers Last Longer - 1 year(s) ago
Research into making asthma and COPD medication more potent could also improve how long inhalers work in patients who need frequent doses.
Categories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
Smoking is the major risk factor for chronic obstructive pulmonary disease (COPD). In IMPACT, single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy significantly reduced moderate/severe exacerbation rates and improved lung function and health status versus FF/VI or UMEC/VI in COPD patients. This post hoc analysis investigated trial outcomes by smoking status.
Source: Respiratory MedicineCategories: Critical Care, Latest HeadlinesTweet
-
Mashup Score: 0
Single vs Multiple Inhaler Triple Therapy in the COPD Population
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
Patients with COPD in England initiating SITT had significantly better adherence and persistence compared with MITT initiators. These improvements continued at least 18 months following treatment initiation.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 1Effectiveness of a digital inhaler system for patients with asthma: a 12-week, open-label, randomized study (CONNECT1) - PubMed - 2 year(s) ago
NCT03890666 (CONNECT1 Clinicaltrial.gov).
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 2
PPPY rates were typically lower with FF/UMEC/VI versus FF/VI or UMEC/VI.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Health literacy and type of education intervention predicting post-education metered-dose inhaler misuse - PubMed - 2 year(s) ago
MDI education with teach-to-goal modalities is more effective than brief intervention; however, patients with low health literacy (disproportionately affecting older patients) may benefit less from these interventions. Further investigation into tailored inhaler education is needed.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Electronic Inhaler Monitoring for Chronic Airway Disease: Development and Application of a Multidimensional Efficacy Framework - 2 year(s) ago
Inhaled therapy is the cornerstone of chronic airway disease therapy, but poor adherence to controller inhalers worsens clinical outcomes and increases cost. Monitoring of controller use is needed to improve adherence, and monitoring of reliever use can predict impending exacerbations. Both can be accurately achieved by electronic inhaler monitoring (EIM). However, evidence for EIM use in…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 2
Inhaled medications are central to treatment of asthma and chronic obstructive pulmonary disease (COPD), yet critical inhaler technique errors are made by up to 90% of patients. In the clinical research setting, recruitment of subjects with poor inhaler technique may give a false impression of both the benefits and the necessity of add-on treatments such as biological therapies.
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 2School Stock Inhaler Statutes and Regulations in the United States: A Systematic Review - PubMed - 2 year(s) ago
Existing stock inhaler laws differ vastly across the United States that may impact access to stock albuterol for children at their schools.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
Researchers are trying to reduce the need for #asthma and #COPD inhaler refills https://t.co/VJ3wfI8a2x #RTmagazine #pharma #inhaler #healthcare